Eli Lilly Corp. buy SVB Leerink LLC
Start price
18.12.25
/
50%
€907.10
Target price
18.12.26
-
Performance (%)
-12.81%
Price
21:32
€790.90
Summary
This prediction is currently active. The prediction for Eli Lilly Corp. disappoints with a performance of -12.81%. This prediction currently runs until 18.12.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Eli Lilly Corp. | -1.269% | -1.269% |
| iShares Core DAX® | 2,55 % | 0,56 % |
| iShares Nasdaq 100 | 2,74 % | -0,60 % |
| iShares Nikkei 225® | 6,58 % | 4,34 % |
| iShares S&P 500 | 1,93 % | -0,51 % |
Comments by SVB_Leerink_LLC for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE:LLY) had its "outperform" rating reaffirmed by analysts at Leerink Partners.
Ratings data for LLY provided by MarketBeat